• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.

作者信息

Angiolillo Dominick J, Bates Eric R

机构信息

Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA.

出版信息

Am Heart J. 2008 Aug;156(2 Suppl):S1-2. doi: 10.1016/j.ahj.2008.06.002.

DOI:10.1016/j.ahj.2008.06.002
PMID:18657679
Abstract

Antiplatelet therapy plays a key role in preventing atherothrombotic complications in patients with acute coronary syndromes and/or undergoing percutaneous coronary interventions. Despite such clinical benefit, currently available agents may present limitations. Several novel antiplatelet medications are currently under advanced clinical testing. Results from ongoing clinical studies will determine the efficacy and safety of these novel agents compared to those currently available.

摘要

相似文献

1
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.
Am Heart J. 2008 Aug;156(2 Suppl):S1-2. doi: 10.1016/j.ahj.2008.06.002.
2
Current antiplatelet therapies: benefits and limitations.当前的抗血小板治疗：益处与局限性。
Am Heart J. 2008 Aug;156(2 Suppl):S3-9. doi: 10.1016/j.ahj.2008.06.003.
3
[Platelet activation in acute coronary syndrome and interventional therapy].[急性冠状动脉综合征与介入治疗中的血小板活化]
Hamostaseologie. 2007 Dec;27(5):338-43.
4
Future perspectives on antithrombin and antiplatelet therapies: novel antiplatelet and antithrombin therapies.抗凝血酶与抗血小板治疗的未来展望：新型抗血小板和抗凝血酶治疗
Rev Cardiovasc Med. 2006;7 Suppl 3:S43-52.
5
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.氯吡格雷用于冠心病患者的获益与风险：来自随机研究和注册登记研究的证据
Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001.
6
Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.经皮冠状动脉介入治疗：评估与裸金属支架和药物洗脱支架相关的冠状动脉血管风险。
Am J Manag Care. 2009 Mar;15(2 Suppl):S42-7.
7
Clinical profile of prasugrel, a novel thienopyridine.新型噻吩并吡啶类药物普拉格雷的临床概况
Am Heart J. 2008 Aug;156(2 Suppl):S16-22. doi: 10.1016/j.ahj.2008.06.005.
8
The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.普拉格雷在急性冠状动脉综合征患者缺血事件二级预防中的潜在作用。
Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955.
9
Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.经皮冠状动脉介入治疗中的抗血小板治疗：普拉格雷在临床实践中的应用
Crit Pathw Cardiol. 2009 Mar;8(1):12-9. doi: 10.1097/HPC.0b013e318196bb46.
10
Antiplatelet medications: old and emerging therapies.抗血小板药物：传统与新兴疗法
Ann Vasc Surg. 2010 Jan;24(1):140-8. doi: 10.1016/j.avsg.2009.03.008. Epub 2009 Jul 19.